Injectable PrEP Drug Faces Access Barriers Amid USAID Funding Cuts
Lenacapavir shows 99% HIV prevention effectiveness, but USAID cuts threaten global access. Experts warn vulnerable populations risk missing breakthrough treatme...
Section
Lenacapavir shows 99% HIV prevention effectiveness, but USAID cuts threaten global access. Experts warn vulnerable populations risk missing breakthrough treatme...